{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:26:12Z","timestamp":1786965972728,"version":"build-2736575974"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,17]]},"DOI":"10.1093\/ehjcvp\/pvag053","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:21:22Z","timestamp":1784546482000},"page":"347-348","source":"Crossref","is-referenced-by-count":0,"title":["Emerging therapies and evolving paradigms in cardiovascular pharmacotherapy"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8304-6423","authenticated-orcid":false,"given":"Bianca","family":"Rocca","sequence":"first","affiliation":[{"name":"Department of Medicine and Surgery, LUM University , Casamassima, Bari 70010 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"2026081706503586700_pvag053-B1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/ehjcvp\/pvaf012","article-title":"New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024","volume":"11","author":"Tamargo","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ehjcvp\/pvag047","article-title":"The OCEANIC trial journey: from failure to breakthrough?","volume":"12","author":"Caso","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/ehjcvp\/pvaf056","article-title":"Post-operative atrial fibrillation and stroke after non-cardiac surgery: a systematic review and meta-analysis","volume":"11","author":"Donati","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ehjcvp\/pvag051","article-title":"The anticoagulation dilemma in postoperative atrial fibrillation after cardiac surgery","volume":"12","author":"Ravn","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ehjcvp\/pvag040","article-title":"Bleeding risk assessment in patients with new-onset atrial fibrillation after coronary surgery: a proof-of-concept study","volume":"12","author":"Rezk","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/ehjcvp\/pvaf037","article-title":"Clinical features modifying the cardiovascular benefits of GLP-1 receptor agonists: a systematic review and meta-analysis","volume":"11","author":"Kalayci","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/ehjcvp\/pvag045","article-title":"Why cardio-rheumatology?","volume":"12","author":"Semb","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/ehjcvp\/pvag044","article-title":"Semaglutide for primary prevention of Major adverse cardiac and cerebrovascular events in patients with type 2 diabetes and comorbid rheumatoid arthritis: a target-trial emulation","volume":"12","author":"Malik","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/ehjcvp\/pvag042","article-title":"Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio-renal-metabolic risk modulation","volume":"12","author":"Borghi","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/ehjcvp\/pvae013","article-title":"New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023","volume":"10","author":"Tamargo","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/ehjcvp\/pvag041","article-title":"Longitudinal loop diuretic use in patients with HFrEF initiated with sodium-glucose cotransporter 2 inhibitors","volume":"12","author":"Tomasoni","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/ehjcvp\/pvag033","article-title":"Management of dyslipidaemia in patients with comorbidities\u2014facing the challenge: heart failure","volume":"12","author":"Drexel","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/ehjcvp\/pvae058","article-title":"Management of dyslipidaemia in patients with comorbidities: facing the challenge","volume":"10","author":"Mayer","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/ehjcvp\/pvae095","article-title":"Management of dyslipidaemia in patients with comorbidities-facing the challenge","volume":"11","author":"Fruhwald","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026081706503586700_pvag053-B15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ehjcvp\/pvaf076","article-title":"Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitus","volume":"11","author":"Drexel","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/5\/347\/70663085\/pvag053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/12\/5\/347\/70663085\/pvag053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:50:42Z","timestamp":1786963842000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/12\/5\/347\/8762401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,8,17]]},"published-print":{"date-parts":[[2026,8,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvag053","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]}}}